STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Ralph, C et al. (17 more authors) (2021) STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Paris, France. Elsevier , S1303-S1304.

Metadata

Authors/Creators:	Brown, JE Royle, K-L https://orcid.org/0000-0003-0225-1199 Ralph, C Meads, D Martin, A https://orcid.org/0000-0002-2559-6483 Howard, H Linsley, C Swain, J Powles, TB Jones, R Eisen, T Maraveyas, A Griffiths, R Din, O Goh, V Wah, T Selby, P Hewison, J https://orcid.org/0000-0003-3026-3250 Brown, J Collinson, F
Dates:	Published: 1 September 2021
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Centre for Health Services Research (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	16 Nov 2021 16:46
Last Modified:	16 Nov 2021 16:53
Status:	Published
Publisher:	Elsevier
Identification Number:	https://doi.org/10.1016/j.annonc.2021.08.2104
Related URLs:	Author

CORE (COnnecting REpositories)

STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)

Metadata

Download not available

Export

Statistics